Noninvasive assessment of liver fibrosis and its clinical significance in nonalcoholic fatty liver disease-Reference-Cited by-同舟云学术

Noninvasive assessment of liver fibrosis and its clinical significance in nonalcoholic fatty liver disease

Published:2022-04-12 Issue:6 Volume:52 Page:497-507
ISSN:1386-6346
Container-title:Hepatology Research
language:en
Short-container-title:Hepatology Research

Author:

Tamaki Nobuharu¹²^ORCID,Kurosaki Masayuki²,Huang Daniel Q.¹³,Loomba Rohit¹⁴

Affiliation:

1. NAFLD Research Center, Division of Gastroenterology and Hepatology, Department of Medicine University of California San Diego La Jolla California USA

2. Department of Gastroenterology and Hepatology Musashino Red Cross Hospital Tokyo Japan

3. Department of Medicine National University of Singapore Singapore Singapore

4. Division of Epidemiology, Department of Family Medicine and Public Health University of California San Diego La Jolla California USA

Funder

National Institute of Diabetes and Digestive and Kidney Diseases

National Center for Advancing Translational Sciences

Japan Agency for Medical Research and Development

National Institute on Alcohol Abuse and Alcoholism

National Heart, Lung, and Blood Institute

Publisher

Wiley

Subject

Infectious Diseases,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/hepr.13764

Reference120 articles.

1. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention

2. The global NAFLD epidemic

3. Epidemiology and natural history of non-alcoholic fatty liver disease

4. Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention

5. NAFLD and increased risk of cardiovascular disease: clinical associations, pathophysiological mechanisms and pharmacological implications

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cardiometabolic criteria as predictors and treatment targets of liver‐related events and cardiovascular events in metabolic dysfunction‐associated steatotic liver disease;Alimentary Pharmacology & Therapeutics;2024-08-08

2. The steatosis‐associated fibrosis estimator score is a useful indicator of recurrence and survival after initial curative hepatectomy for hepatocellular carcinoma;Annals of Gastroenterological Surgery;2024-07-23

3. Posicionamiento sobre manejo perioperatorio y riesgo quirúrgico en el paciente con cirrosis;Revista de Gastroenterología de México;2024-07

4. Position paper on perioperative management and surgical risk in the patient with cirrhosis;Revista de Gastroenterología de México (English Edition);2024-07

5. Enhanced Liver Fibrosis Score for Diagnosing Liver Fibrosis in Chronic Hepatitis;Diagnostics;2024-06-21